Riskpilot← Back to searchSign inGet full accessYarwaessi AB
ABActiveOrg 5590254487Economic activity was not specified by tax authority · NACE 0000Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
-123% vs 2023
Equity ratio
81.5%
Financial strength
Net profit 2024
SEK -33K
-123% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -33K | -123% |
| Net profit | SEK -33K | -123% |
| Total assets | SEK 1,6M | +0% |
| Equity | SEK 1,3M | -3% |
| Employees | 0 | — |
Legal name
Yarwaessi AB
Org number
5590254487
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
4 september 2015
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att förvalta aktier i bolag som bedriver apoteksverksamhet samt att, direkt eller indirekt, äga och förvalta övrig fast och lös egendom och därmed förenlig verksamhet.
Address
Email
soran.yarwaessi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −19 | −16 | −11 | −15 | −33 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | −19 | −16 | −11 | −15 | −33 |
| Net financials | — | 396 | 850 | — | 0 |
| Profit before tax | −19 | 380 | — | −15 | — |
| Tax | −0 | −0 | — | −0 | — |
| Net profit | −19 | 380 | 839 | −15 | −33 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 584 | 1 901 | 1 591 | 1 584 | 1 584 |
| Equity | 121 | 501 | 1 339 | 1 324 | 1 291 |
| Long-term debt | 1 381 | 1 081 | 231 | 231 | 231 |
| Short-term debt | 82 | 320 | 21 | 29 | 62 |
| Total debt | 1 463 | 1 401 | 252 | 260 | 293 |
EBITDA margin
-3343200.0%
This company
15.8%
Market median
-21159594% vs market
20202024
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
-2.6%
This company
18.4%
Market median
-114% vs market
20202024
Net profit margin
-3339400.0%
This company
8.1%
Market median
-41227260% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JK Chief Auditor | Chief Auditor | 2022 |
SB Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
SM Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Yarwaessi AB 
Ekeby Apotek ABBoard members of Yarwaessi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Karl Lahiru Nilsson | Chief Auditor | 0 companies |
| Soran Bahjat Khalid | Chief Executive Officer | 0 companies |
| Sara Maria Kristina Andersson | Chief Auditor | 0 companies |
| Evin Ahmad | Chairman | 0 companies |
| Dilan Ahmad | Deputy Board Member | 0 companies |